Yuji Minegishi

Breast Cancer Resistance Protein Impacts Clinical Outcome in Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer

Kiyotaka Yoh, Genichiro Ishii, Tomoyuki Yokose et al. · Clinical Cancer Research · 2004 · 242 citations · Full text

Medicine, Oncology, Pharmacology +16

Effectiveness of Gefitinib against Non–Small-Cell Lung Cancer with the Uncommon EGFR Mutations G719X and L861Q

Satoshi Watanabe, Yuji Minegishi, Hirohisa Yoshizawa et al. · Journal of Thoracic Oncology · 2014 · 204 citations · Full text

Medicine, Oncology, Pharmacology +12

Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation

Kazuyoshi Kato, Tsutomu Ogura, Atsuhiro Kishimoto et al. · Oncogene · 2002 · 194 citations

Life Sciences, Cancer Biology, Oncology +17

MiR-134/487b/655 Cluster Regulates TGF-β–Induced Epithelial–Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting <i>MAGI2</i> in Lung Adenocarcinoma Cells

Kazuhiro Kitamura, Masahiro Seike, Tetsuya Okano et al. · Molecular Cancer Therapeutics · 2013 · 186 citations · Full text

Medicine, Cancer Biology, Oncology +17

MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells

Mengru Cao, Masahiro Seike, Chie Soeno et al. · International Journal of Oncology · 2012 · 169 citations · Full text

Life Sciences, Cell Biology, Oncology +17